Ignite Creation Date:
2024-05-06 @ 2:54 PM
Last Modification Date:
2024-10-26 @ 1:39 PM
Study NCT ID:
NCT04460430
Status:
TERMINATED
Last Update Posted:
2022-10-25
First Post:
2020-06-29
Brief Title:
Targeting EGFRERBB2 With Neratinib in Hormone Receptor HR-PositiveHER2-negative HER2-enriched AdvancedMetastatic Breast Cancer
Sponsor:
Organization:
SOLTI Breast Cancer Research Group